IN188856B - - Google Patents

Info

Publication number
IN188856B
IN188856B IN625MU2000A IN188856B IN 188856 B IN188856 B IN 188856B IN 625MU2000 A IN625MU2000 A IN 625MU2000A IN 188856 B IN188856 B IN 188856B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Sanjeev H Kothari
Divyakant S Desai
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24186805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN188856(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IN188856B publication Critical patent/IN188856B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN625MU2000 2000-04-12 2000-07-06 IN188856B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54794800A 2000-04-12 2000-04-12

Publications (1)

Publication Number Publication Date
IN188856B true IN188856B (en:Method) 2002-11-16

Family

ID=24186805

Family Applications (1)

Application Number Title Priority Date Filing Date
IN625MU2000 IN188856B (en:Method) 2000-04-12 2000-07-06

Country Status (43)

Country Link
US (3) US20100016448A1 (en:Method)
EP (2) EP1566174A3 (en:Method)
JP (1) JP3773763B2 (en:Method)
KR (1) KR100477293B1 (en:Method)
CN (1) CN100353933C (en:Method)
AR (1) AR024384A1 (en:Method)
AT (1) ATE328584T1 (en:Method)
AU (1) AU752214B2 (en:Method)
BG (1) BG65007B1 (en:Method)
BR (1) BR0003158A (en:Method)
CA (1) CA2311734C (en:Method)
CO (1) CO5190672A1 (en:Method)
CY (1) CY1105170T1 (en:Method)
CZ (1) CZ299145B6 (en:Method)
DE (1) DE60028536T2 (en:Method)
DK (1) DK1145711T3 (en:Method)
EE (1) EE04331B1 (en:Method)
EG (1) EG23943A (en:Method)
ES (1) ES2265836T3 (en:Method)
GE (1) GEP20022851B (en:Method)
HK (1) HK1039572B (en:Method)
HU (1) HU228864B1 (en:Method)
ID (1) ID29837A (en:Method)
IL (1) IL136901A (en:Method)
IN (1) IN188856B (en:Method)
LT (1) LT4896B (en:Method)
LV (1) LV12731B (en:Method)
MY (1) MY125766A (en:Method)
NO (1) NO330270B1 (en:Method)
NZ (1) NZ505302A (en:Method)
PE (1) PE20010298A1 (en:Method)
PL (1) PL200409B1 (en:Method)
PT (1) PT1145711E (en:Method)
RO (1) RO118563B1 (en:Method)
RU (1) RU2201216C2 (en:Method)
SG (2) SG117445A1 (en:Method)
SI (1) SI20511B (en:Method)
SK (1) SK286368B6 (en:Method)
TR (1) TR200001810A3 (en:Method)
TW (1) TWI262799B (en:Method)
UA (1) UA63993C2 (en:Method)
UY (1) UY26306A1 (en:Method)
ZA (1) ZA200003121B (en:Method)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
US20020076437A1 (en) 2000-04-12 2002-06-20 Sanjeev Kothari Flashmelt oral dosage formulation
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
KR20040100835A (ko) 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
MY129350A (en) * 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
MY138669A (en) * 2001-09-25 2009-07-31 Otsuka Pharma Co Ltd Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
GB0123400D0 (en) * 2001-09-28 2001-11-21 Novartis Ag Organic compounds
CA2462886C (en) * 2001-10-09 2013-07-30 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
US6610266B2 (en) 2001-11-28 2003-08-26 Michael C. Withiam Calcium metasilicates and methods for making
WO2003050110A1 (en) * 2001-12-10 2003-06-19 Dr. Reddy's Laboratories Ltd. Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
EP1488811A1 (en) * 2002-03-06 2004-12-22 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
WO2003086343A2 (en) * 2002-04-05 2003-10-23 Cadila Healthcare Limited Fast disintegrating oral dosage forms
MY131488A (en) * 2002-04-08 2007-08-30 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
UA79984C2 (en) 2002-08-20 2007-08-10 Bristol Myers Squibb Co Preparation on the basis of aripiprazole complex and use thereof
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
CA2508811C (en) * 2002-12-11 2014-11-18 Bristol-Myers Squibb Company Process for preparing the antiviral agent [1s-(1.alpha., 3.alpha., 4.beta.)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
RU2253451C1 (ru) * 2004-03-15 2005-06-10 Общество с ограниченной ответственностью "ЮНАЛ" Антиаллергическое средство
ES2282062T1 (es) 2004-06-04 2007-10-16 Teva Pharmaceutical Industries Ltd. Composicion farmaceutica que contiene irbesartan.
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠
KR20140065482A (ko) * 2005-03-24 2014-05-29 다이이찌 산쿄 가부시키가이샤 의약용 조성물
TWI383809B (zh) * 2005-06-29 2013-02-01 Otsuka Pharma Co Ltd 含有西洛他唑（ｃｉｌｏｓｔａｚｏｌ）之口腔崩解粉末
PL1808165T3 (pl) * 2006-01-05 2009-09-30 Teva Pharma Suche formulacje aripiprazolu
ATE419837T1 (de) 2006-01-05 2009-01-15 Teva Pharma Feuchtgranulierungsmethode zur herstellung pharmazeutischer aripiprazolzusammensetzungen
SI1806130T1 (sl) * 2006-01-09 2010-06-30 KRKA@@d@d@@@Novo@mesto Trden farmacevtski sestavek ki obsega irbesartan
JP5535616B2 (ja) 2006-03-31 2014-07-02 ルビコン リサーチ プライベート リミテッド 口腔内崩壊錠剤のための直接圧縮性複合材
LT2487163T (lt) 2007-02-23 2016-10-25 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai
US20100104640A1 (en) * 2007-04-17 2010-04-29 Ratiopharm Gmbh Pharmaceutical compositions comprising irbesartan
CN101677945A (zh) * 2007-05-08 2010-03-24 赫尔克里士公司 坚固的快速崩解片剂制剂
CN101322709B (zh) * 2007-06-12 2011-03-02 成都康弘药业集团股份有限公司 一种含有阿立哌唑的药物组合物及其制备方法
CN102123700A (zh) 2008-05-02 2011-07-13 吉里德科学公司 固体载体颗粒在改善药物制剂加工性中的应用
JP5296456B2 (ja) * 2008-08-26 2013-09-25 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2010106936A1 (ja) * 2009-03-16 2010-09-23 ニプロ株式会社 口腔内崩壊錠
WO2010146551A2 (en) * 2009-06-16 2010-12-23 Ranbaxy Laboratories Limited Orally disintegrating compositions comprising antihypertensive agents
WO2011032882A1 (en) 2009-09-15 2011-03-24 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
TR201000689A1 (tr) * 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Sefprozil içeren katı dozaj formlar.
CN103284968B (zh) * 2010-04-13 2015-11-18 齐鲁制药有限公司 一种阿立哌唑组合物微晶的口腔崩解片及其制备方法
EP2384742A1 (en) 2010-05-03 2011-11-09 The Jordanian Pharmaceutical Manufacturing Co. Pharmaceutical excipient, method for its preparation and use thereof
DE102010019416A1 (de) * 2010-05-04 2011-11-10 Stada Arzneimittel Ag Schmelztablette, umfassend ein Triptan oder ein atypisches Neuroleptikum
HU1000278D0 (en) 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
HRP20161549T1 (hr) 2011-03-18 2016-12-30 Alkermes Pharma Ireland Limited Injektabilni farmaceutski pripravci koji sadrže antipsihotik koji je netopljiv u vodi, sorbitan laurat i polisorbat 20
EP3854376A3 (en) * 2011-03-21 2021-12-22 Coloright Ltd. Systems for custom coloration
WO2013000391A1 (zh) * 2011-06-27 2013-01-03 上海中西制药有限公司 一种阿立哌唑药物制剂及其制备方法
CN102846564B (zh) * 2011-06-28 2013-10-09 南京亿华药业有限公司 一种头孢丙烯片及其制法
CN102357086A (zh) * 2011-11-01 2012-02-22 上海理工大学 一种头孢丙烯口腔崩解片
JP2015504878A (ja) * 2011-12-26 2015-02-16 ノバルティス アーゲー 錠剤及び有核剤
ES2764383T3 (es) 2012-03-19 2020-06-03 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que comprenden ésteres de glicerol
ES2950418T3 (es) 2012-03-19 2023-10-09 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que comprenden alcohol bencílico
EP2827868B8 (en) 2012-03-19 2019-12-18 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising fatty acid esters
WO2013175508A2 (en) 2012-05-24 2013-11-28 Medreich Limited Stable pharmaceutical composition of aripiprazole
CA2779052A1 (en) * 2012-05-31 2013-11-30 Pharmascience Inc. Pharmaceutical composition of entecavir and process of manufacturing
KR101571670B1 (ko) 2012-08-08 2015-11-25 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제
US20150224086A1 (en) * 2012-08-23 2015-08-13 Hetero Research Foundation Pharmaceutical Formulations of Rufinamide
JP6654042B2 (ja) 2012-09-19 2020-02-26 アルカームス ファーマ アイルランド リミテッド 貯蔵安定性が改善された医薬組成物
CN102885790B (zh) * 2012-09-20 2013-12-25 中国人民解放军第三〇二医院 恩替卡韦分散片及其制备方法
EP2838513B1 (en) 2013-04-30 2017-04-05 Otsuka Pharmaceutical Co., Ltd. Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
JP5714652B2 (ja) * 2013-06-13 2015-05-07 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2015067313A1 (en) 2013-11-07 2015-05-14 Synthon B.V. Orodispersible pharmaceutical compositions comprising aripiprazole
CA2943213C (en) 2014-03-20 2022-07-05 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
JP5978335B2 (ja) * 2015-03-11 2016-08-24 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
KR20160139704A (ko) 2015-05-28 2016-12-07 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제, 및 이의 제조방법
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
US9855227B2 (en) 2015-12-18 2018-01-02 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form
TR201617675A2 (tr) 2016-12-02 2018-06-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Ari̇pi̇prazole monohi̇drat formülasyonlarinin ağizda dağilan tablet formu
JP6572257B2 (ja) * 2017-05-16 2019-09-04 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
JP2017141299A (ja) * 2017-05-24 2017-08-17 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2019173230A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
JP2018168185A (ja) * 2018-07-05 2018-11-01 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2019203031A (ja) * 2019-09-06 2019-11-28 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
RU2732291C1 (ru) * 2020-02-13 2020-09-15 Открытое акционерное общество "Фармстандарт-Лексредства" (ОАО "Фармстандарт-Лексредства") Лекарственный препарат на основе травы алтея лекарственного для лечения простудных и острых респираторных заболеваний
GB2617603B (en) * 2022-04-13 2025-06-04 Univ Brunel Compositions for preventing and treating infection
CN115227661B (zh) * 2022-09-22 2022-12-13 北京惠之衡生物科技有限公司 一种利格列汀片及其制备方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1912354B2 (de) * 1969-03-12 1972-04-13 Reimbold & Strick, 5000 Köln-Kalk Synthetisches kristallines calciumsilikat und verfahren zu seiner herstellung
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
FR2234244B1 (en:Method) * 1973-06-20 1978-02-17 Rech Geolog Miniere
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
DE2849494A1 (de) 1978-11-15 1980-05-29 Voss Gunter M Verfahren zur herstellung von arzneimittel-formlingen
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS59106473A (ja) * 1982-12-10 1984-06-20 Nippon Shinyaku Co Ltd トリアジン誘導体
ZA87279B (en) 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
SE8601624D0 (sv) 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
US5032552A (en) * 1988-07-04 1991-07-16 Tdk Corporation Biomedical material
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
HU203041B (en) 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
JPH06271744A (ja) * 1993-03-22 1994-09-27 Mizusawa Ind Chem Ltd ポリアセタール系樹脂用帯電防止剤
US5393472A (en) * 1993-06-30 1995-02-28 Shaw; John D. Method of producing wollastonite & ceramic bodies containing wollastonite
IL110376A (en) * 1993-08-02 1998-08-16 Bristol Myers Squibb Co Pharmaceutical compositions containing ifetroban salts and methods for the preparation thereof
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
WO1996004914A1 (fr) * 1994-08-08 1996-02-22 Nippon Shinyaku Co., Ltd. Derive de triazine et medicament
TW318841B (en:Method) * 1995-02-17 1997-11-01 Takeda Pharm Industry Co Ltd
TW442301B (en) * 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
US6103007A (en) * 1995-11-17 2000-08-15 Vrije Universiteit Brussel Inorganic resin compositions, their preparation and use thereof
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
WO1997031639A1 (fr) * 1996-02-29 1997-09-04 Fujisawa Pharmaceutical Co., Ltd. COMPRIMES CONTENANT UN ANTIBIOTIQUE AU β-LACTAME ET PROCEDE POUR LEUR PRODUCTION
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
ATE291930T1 (de) * 1996-07-12 2005-04-15 Daiichi Seiyaku Co Schnell zerfallende, druckgeformte materialien sowie prozess zu deren herstellung
EP0918456A1 (en) * 1996-07-23 1999-06-02 Fmc Corporation Disintegrant composition for dispersible solids
JPH10114655A (ja) 1996-10-09 1998-05-06 Kyowa Hakko Kogyo Co Ltd 固形製剤
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
AUPO446397A0 (en) 1997-01-07 1997-01-30 Rees Equipment Pty Ltd Agricultural equipment direction control
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
JPH11152220A (ja) * 1997-11-19 1999-06-08 Daiichi Yakuhin Kogyo Kk 脂溶性薬物を含有した丸剤の製造方法
AR014133A1 (es) * 1997-12-19 2001-02-07 Smithkline Beecham Corp Procedimiento para fabricar tabletas de dispersion rapida para administracion oral y una formulacion de dichas tabletas
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
JP2002505269A (ja) 1998-03-06 2002-02-19 エウランド インターナショナル ソシエタ ペル アチオニ 急速崩壊錠剤
JP4027535B2 (ja) 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 脂溶性薬物を含有した粉末
CO5070643A1 (es) * 1998-05-27 2001-08-28 Merck & Co Inc Formulacion en tabletas comprimidas
JP2000119014A (ja) 1998-08-12 2000-04-25 Fuji Chem Ind Co Ltd 無晶形ケイ酸アルミン酸カルシウム複合酸化物及びその製造方法並びに制酸剤
JP2000086537A (ja) 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
US6133378A (en) * 1998-11-20 2000-10-17 Bridgestone/Firestone, Inc. EPDM-based roofing shingle compositions
GB9914936D0 (en) 1999-06-26 1999-08-25 Cerestar Holding Bv Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets
US20020076437A1 (en) * 2000-04-12 2002-06-20 Sanjeev Kothari Flashmelt oral dosage formulation
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
CA2447370A1 (en) 2001-06-29 2003-01-09 Xanoptix, Inc. High-precision female format multifiber connector
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
US6610266B2 (en) * 2001-11-28 2003-08-26 Michael C. Withiam Calcium metasilicates and methods for making

Also Published As

Publication number Publication date
NO20003196L (no) 2001-10-15
IL136901A (en) 2008-03-20
ATE328584T1 (de) 2006-06-15
DE60028536D1 (de) 2006-07-20
RO118563B1 (ro) 2003-07-30
BG104693A (en) 2002-02-28
SK9732000A3 (en) 2001-11-06
RU2201216C2 (ru) 2003-03-27
NO330270B1 (no) 2011-03-14
PL341466A1 (en) 2001-10-22
EE04331B1 (et) 2004-08-16
KR20010096450A (ko) 2001-11-07
EE200000497A (et) 2001-12-17
PT1145711E (pt) 2006-11-30
EP1566174A3 (en) 2007-04-04
CN1317309A (zh) 2001-10-17
ES2265836T3 (es) 2007-03-01
LT4896B (lt) 2002-02-25
UY26306A1 (es) 2001-12-28
US20100016448A1 (en) 2010-01-21
PL200409B1 (pl) 2009-01-30
ID29837A (id) 2001-10-18
CZ20002391A3 (cs) 2001-11-14
TWI262799B (en) 2006-10-01
AU752214B2 (en) 2002-09-12
DE60028536T2 (de) 2007-05-16
HK1039572A1 (en) 2002-05-03
US20130296337A1 (en) 2013-11-07
MY125766A (en) 2006-08-30
DK1145711T3 (da) 2006-10-02
SG108230A1 (en) 2005-01-28
PE20010298A1 (es) 2001-05-20
UA63993C2 (uk) 2004-02-16
LV12731A (en) 2001-10-20
EP1145711A1 (en) 2001-10-17
SI20511A (sl) 2001-10-31
CN100353933C (zh) 2007-12-12
HU0002316D0 (en) 2000-08-28
NZ505302A (en) 2001-12-21
NO20003196D0 (no) 2000-06-20
TR200001810A2 (tr) 2001-11-21
TR200001810A3 (tr) 2001-11-21
SK286368B6 (sk) 2008-08-05
AR024384A1 (es) 2002-10-02
JP3773763B2 (ja) 2006-05-10
HUP0002316A2 (hu) 2002-11-28
CY1105170T1 (el) 2010-03-03
AU4373300A (en) 2001-10-18
LV12731B (en) 2002-03-20
BR0003158A (pt) 2001-12-18
EP1145711B1 (en) 2006-06-07
CA2311734C (en) 2011-03-08
CA2311734A1 (en) 2001-10-12
CZ299145B6 (cs) 2008-04-30
SI20511B (sl) 2008-08-31
JP2001302499A (ja) 2001-10-31
US8518421B2 (en) 2013-08-27
SG117445A1 (en) 2005-12-29
HUP0002316A3 (en) 2008-04-28
EG23943A (en) 2008-01-22
LT2000064A (en) 2001-10-25
ZA200003121B (en) 2001-12-21
US20110217342A1 (en) 2011-09-08
GEP20022851B (en) 2002-12-25
BG65007B1 (bg) 2006-12-29
KR100477293B1 (ko) 2005-03-17
US9358207B2 (en) 2016-06-07
HU228864B1 (en) 2013-06-28
CO5190672A1 (es) 2002-08-29
IL136901A0 (en) 2001-06-14
EP1566174A2 (en) 2005-08-24
HK1039572B (en) 2007-01-12

Similar Documents

Publication Publication Date Title
BE2017C009I2 (en:Method)
BE2012C016I2 (en:Method)
BRPI0113085B8 (en:Method)
IN188856B (en:Method)
JP2003518804A5 (en:Method)
JP2002184449A5 (en:Method)
JP2003503720A5 (en:Method)
JP2001239297A5 (en:Method)
BRPI0113372A8 (en:Method)
JP2000304080A5 (en:Method)
JP2001255690A5 (en:Method)
JP2002133278A5 (en:Method)
JP2002534755A5 (en:Method)
JP2002197206A5 (en:Method)
CH694022C1 (en:Method)
JP2001228234A5 (en:Method)
JP2001202637A5 (en:Method)
JP2001324365A5 (en:Method)
BY5768C1 (en:Method)
BRPI0003419A (en:Method)
JP2001245590A5 (en:Method)
CN300955183S (zh) 连接件
JP2002086888A5 (en:Method)
JP2001290032A5 (en:Method)
HU0004197D0 (en:Method)